Technology · Bioproduction & equipment / Fill-finish & packaging

mRNA / LNP manufacturing equipment

The mixers, skids and continuous-flow reactors that bring an mRNA payload and a four-lipid ethanol blend together in microseconds to self-assemble 80–120 nm lipid nanoparticles — the hardware layer behind every commercial mRNA vaccine and the in-vivo delivery system for the next generation of gene therapy.

Risk: low Advanced therapies Bioprocess equipment US · CN · EU Science: why it works → verified 2026-07-25 · 5 Sources (0 independent)

1 · What it gives

mRNA / LNP manufacturing equipment is the set of mixers, skids and continuous-flow reactors that combine an aqueous mRNA stream with an ethanol-dissolved lipid blend so the four components — ionizable lipid, cholesterol, helper phospholipid and PEG-lipid — self-assemble around the mRNA into lipid nanoparticles of 80–120 nm in a few milliseconds. Two mixing geometries dominate the commercial field: impingement-jet mixing (IJM), which collides the two streams head-on inside a confined chamber at high velocity, and microfluidic staggered-herringbone mixing, which interleaves the streams in a lithographic channel. Both run continuously, scale by holding residence time constant, and feed straight into a downstream tangential-flow filtration (TFF) step that removes the ethanol and conditions the buffer before sterile fill-finish. The platform is the hardware layer behind the multi-billion-dose mRNA COVID-19 vaccines and the in-vivo delivery system for a fast-growing pipeline of gene-editing, vaccine and protein-replacement therapies.

The key directions of mRNA / LNP manufacturing equipment are:

Benchtop microfluidic screening (NanoAssemblr Ignite/Spark): milligram-scale staggered-herringbone mixers that let formulators sweep the flow-rate ratio, lipid composition and N/P ratio in overnight design-of-experiments runs before committing to GMP scale.
GMP impingement-jet skids (Knauer IJM NanoScaler/NanoProducer): the high-velocity collision geometry used to manufacture commercial mRNA vaccines, scaled by Reynolds-number matching from a benchtop NanoScaler to a multi-litre-per-minute production skid.
Production microfluidic platforms (NanoAssemblr Blaze/Gemini, Microfluidizer M7250): parallelised microfluidic cartridges or high-pressure interaction chambers delivering kilograms of mRNA-LNP per batch under single-use, GMP-clean flow paths.
Continuous-flow reactors (Corning Advanced-Flow Reactor): structured plate-and-frame continuous reactors (G1–G4) that turn LNP formation into a true continuous process aligned with ICH Q13, rather than a batch-overflowing stirred vessel.

Sectoral value chain#

[lipid & mRNA preparation] ──> [continuous mixing (IJM/microfluidic/AFR)] ──> [quench & dilution]
                                                │
                                  (downstream TFF + sterile filtration)
                                                │
                                                ▼
[distribution & cold chain] <─── [fill-finish] <─────┘

Value chain levels#

Level	Description	Key inputs/outputs
Lipid & mRNA preparation	dissolving the four-lipid blend in ethanol and the mRNA in aqueous buffer	In: ionizable lipid, cholesterol, helper lipid, PEG-lipid, mRNA bulk. Out: two feed streams.
Continuous mixing	IJM, microfluidic or AFR contactor bringing the streams together at a tuned flow-rate ratio	In: two feed streams. Out: crude mRNA-LNP in ~30–50% ethanol.
Quench & dilution	immediate buffer dilution to stabilise the particle and stop growth	In: crude mRNA-LNP. Out: diluted LNP dispersion.
Downstream TFF	tangential-flow filtration to remove ethanol and exchange buffer	In: diluted dispersion. Out: formulated mRNA-LNP (<1% ethanol).
Sterile filtration & fill	0.22 μm filtration into vials, syringes or bags under GMP Annex 1	In: formulated LNP. Out: filled drug product.
Cold-chain distribution	frozen or refrigerated logistics at -70 °C to 2–8 °C to point of use	In: filled drug product. Out: administered dose.

Cross-cutting technologies of the sector:

Impingement-jet mixing (Impingement-Jet Mixing): high-velocity stream collision in a confined chamber, the commercial-scale mixer geometry behind mRNA COVID-19 vaccines.
Microfluidic LNP formulation (Microfluidic LNP Formulation): lithographic-channel mixing that controls LNP size (30–270 nm) by tuning flow-rate ratio.
Tangential-flow filtration (Tangential-Flow Filtration): the downstream ethanol-removal and buffer-exchange step that every continuous mixer feeds into.

2 · What it replaces 3 · matched by industry

D1E–	Fermentation (stainless and single-use bioreactors, solid-state reactors) and downstream equipment (centrifuges, filtration, spray and fluid-bed drying, formulation) for local production of enzymes, microbial products and fermentation ingredients instead of chemical-synthesis plants and imports Replaces: Chemical-synthesis routes and imports for the products in FI-, FD-, I- and A-series articles (enzymes, organic acids, vitamins, microbial …	EAC
D1E3	Process equipment for residue-to-product plants — anaerobic digesters and biogas upgrading, composting turners and granulation lines, biomass pelleting, pyrolysis and carbonization kilns — instead of incinerators, landfill, open lagoons and open burning Replaces: Landfill and open dumping of organic waste; open burning of crop residues; open anaerobic lagoons; incineration of wet organic waste	EAC
D1E4	On-farm and regional biofactories (multiplication units, media, quality control) for microbial bio-inputs — Bacillus, Trichoderma, Beauveria, Bt, beneficial insects — instead of importing finished chemical pesticides and fertilizers Replaces: Imported finished synthetic pesticides and part of mineral fertilizer programmes; also imported finished biologicals with long cold chains	EAC

3 · How to implement 6 steps

1
Lipid and mRNA feed preparationFormulation & blending
The four-lipid blend (ionizable lipid, cholesterol, helper phospholipid, PEG-lipid) is dissolved in ethanol, and the mRNA bulk — produced by in-vitro transcription and purified — is held in aqueous buffer as two separate feed streams.
Who can do this step matched automatically
SyAqua Group Thailand
“vannamei genetics (broodstock, nauplii, and post-larvae) built on genomic selection/marker-assisted selection plus quantitative genetics (BLUP), with disease resistance screening …”
Silvateam Italy
✓ ISO 9001 15,000 tons per year industrial scale
“Production of feed additives and premixtures”
Advanced Enzyme Technologies (NSE) India
✓ ISO 9001 500 m3
“This is a satellite blending, mixing and formulation facility, located at Vashind near Shahapur and dedicated to the company’s Animal Nutrition business.”
2
Continuous mixingFormulation & blending
The two streams meet in the mixer contactor — impingement-jet (Knauer IJM), staggered-herringbone microfluidic (NanoAssemblr), high-pressure interaction chamber (Microfluidizer) or plate-and-frame (Corning AFR) — at a tuned flow-rate ratio (typically ~1:3 organic:aqueous) and controlled total flow, self-assembling 80–120 nm lipid nanoparticles in milliseconds.
Who can do this step matched automatically
SyAqua Group Thailand
“vannamei genetics (broodstock, nauplii, and post-larvae) built on genomic selection/marker-assisted selection plus quantitative genetics (BLUP), with disease resistance screening …”
Silvateam Italy
✓ ISO 9001 15,000 tons per year industrial scale
“Production of feed additives and premixtures”
Advanced Enzyme Technologies (NSE) India
✓ ISO 9001 500 m3
“This is a satellite blending, mixing and formulation facility, located at Vashind near Shahapur and dedicated to the company’s Animal Nutrition business.”
3
Quench and dilution
The crude LNP dispersion, still in ~30–50% ethanol, is immediately diluted with buffer to stabilise particle size, stop growth and bring encapsulation efficiency above 90%.
4
Downstream TFFPurification & downstream
Single-use tangential-flow filtration cassettes remove the ethanol and exchange the buffer down to <1% residual organic, with inline DLS PAT confirming particle size and polydispersity hold.
Who can do this step matched automatically
Esco Aster Singapore
✓ ISO 9001 5,000 L industrial scale
“Adherent cell culture and downstream processing: commercialized Tide Motion bioreactor platform (MiniTide to TideXcell) with closed automated cell harvesting and single-use …”
Tsukishima Kikai Japan
✓ ISO 9001
“Crystallization and refining: In-house developed DP Crystallizer and Oslo Crystallizer for tailored crystallization and refining processes; integrated purification units combining …”
HLB Genex (ex-GenoFocus) South Korea
industrial scale
“With fungal and bacterial secretion systems, we custom produce the evolved enzyme products in large-scale fermentation and downstream processes.”
Advanced Enzyme Technologies (NSE) India
✓ ISO 9001 500 m3
“Development of robust, scalable fermentation and downstream processing (production and recovery/yield optimization).”
5
Sterile filtrationPurification & downstream
The formulated LNP passes a 0.22 μm sterile filter into the fill-finish suite under EU GMP Annex 1 aseptic conditions, with container-closure integrity verified per batch.
Who can do this step matched automatically
Esco Aster Singapore
✓ ISO 9001 5,000 L industrial scale
“Adherent cell culture and downstream processing: commercialized Tide Motion bioreactor platform (MiniTide to TideXcell) with closed automated cell harvesting and single-use …”
Tsukishima Kikai Japan
✓ ISO 9001
“Crystallization and refining: In-house developed DP Crystallizer and Oslo Crystallizer for tailored crystallization and refining processes; integrated purification units combining …”
HLB Genex (ex-GenoFocus) South Korea
industrial scale
“With fungal and bacterial secretion systems, we custom produce the evolved enzyme products in large-scale fermentation and downstream processes.”
Advanced Enzyme Technologies (NSE) India
✓ ISO 9001 500 m3
“Development of robust, scalable fermentation and downstream processing (production and recovery/yield optimization).”
6
Fill-finish and cold chainPackaging & fill-finish
The sterile LNP drug product is filled into vials, syringes or bags, lyophilised or frozen where required, and distributed at -70 °C to 2–8 °C through validated cold chain to the point of administration.
Who can do this step matched automatically
Pakka (ex-Yash Pakka) India
1940 MT per annum industrial scale
“Pakka Limited (located in Ayodhya, India) provides regenerative packaging solutions for food products.”
RWDC Industries Singapore
industrial scale
“2026-04-02 [A Major Step Forward in the Fight Against Microplastics — RWDC Industries is positioning itself as a leader in sustainable biopolymers, specifically Solon PHA, a fully …”

4 · Who delivers

Matched suppliers (matched automatically)

Evonik	Germany	Producer	active
Praj Industries (NSE)	India	Services / consulting	active
Holiferm	United Kingdom	Research / RTO	active
Brevel	Israel	Producer	active
Genus	United Kingdom	Distributor	active

In the services and supply catalogue 3 · paid service

Engineering, EPC & validation · Fill-finish & lyophilisation · Single-use assemblies & bags

Leading companies and institutes (from the brief)

Company / Institute	Country	Key products / platforms	Tech features	Status 2026
Precision NanoSystems	🇨🇦 Canada	NanoAssemblr Ignite/Spark/Blaze/Gemini	Staggered-herringbone microfluidic mixer (Cytiva company); scales 1 mL to multi-litre continuous Bio-Continuum	Commercial
Knauer	🇩🇪 Germany	IJM NanoScaler, NanoProducer	Impingement-jet collision mixer scaled by Reynolds number; commercial mRNA vaccine manufacturing	Commercial
Microfluidics International	🇺🇸 USA	Microfluidizer LM20, M7250	High-pressure fixed-geometry interaction chamber; sub-100 nm LNP at production scale	Commercial
Corning	🇺🇸 USA	Advanced-Flow Reactor G1–G4	Plate-and-frame continuous reactor qualified for LNP/mRNA under ICH Q13	Commercial
Evonik	🇩🇪 Germany	Wilshire continuous processing, lipid supply	LNP CDMO pairing lipid manufacturing with continuous/high-shear processing	Commercial

5 · Rules & route to market

Route into Russia / EAEU: EAC · EAEU accredited bodies / Rosakkreditatsiya
declaration registered within 3 working days (testing extra); certification longer
Information, not legal advice — confirm the procedure for your product. (2026-10-06)

United States

The United States is the centre of the microfluidic-mixing platform class, and the home of two of its three dominant hardware vendors: Precision NanoSystems (Vancouver, CA, a Cytiva company since 2020) and Microfluidics International (Westwood, MA). Corning (Corning, NY) adds the continuous Advanced-Flow Reactor family, and FDA’s emergency-use and full-approval pathways for mRNA vaccines are what pulled the platform from research into multi-billion-dose commercial scale.

microfluidic mixer platforms, AFR continuous reactors, FDA mRNA pathway#

Precision NanoSystems — NanoAssemblr: the staggered-herringbone platform (Ignite benchtop, Spark clinical, Blaze and Gemini commercial, Bio-Continuum continuous manufacturing) that set the de-facto LNP-process-development standard.
Microfluidics International — Microfluidizer: high-pressure fixed-geometry interaction chambers (LM20 benchtop, M7250 production) producing uniform sub-100 nm LNP across high-shear homogenisation.
Corning — Advanced-Flow Reactor (AFR): the G1–G4 plate-and-frame continuous reactor class, qualified for LNP and mRNA continuous manufacturing under ICH Q13.

European Union

Europe anchors the impingement-jet side of the field and the CDMO offer: Knauer (Berlin, DE) builds the IJM skid family that manufactures commercial mRNA vaccines, while Evonik (Essen, DE) operates a lipid and LNP contract-development-and-manufacturing network expanded through the 2024 Wilshire acquisition, and EMA’s EU GMP Annex 1 and ICH Q13 guidance define the aseptic and continuous-manufacturing bar.

impingement-jet skids, lipid/CDMO capacity, GMP Annex 1#

Knauer — IJM NanoScaler & NanoProducer: the impingement-jet family scaled by Reynolds-number matching from benchtop NanoScaler to production NanoProducer, developed with partners such as XNApharma for RNA delivery screening.
Evonik — Wilshire continuous processing & lipids: Evonik Health Care’s LNP CDMO, expanded through the Wilshire acquisition, pairs lipid supply with continuous processing and high-shear expertise.
EMA GMP Annex 1 & ICH Q13: the EU aseptic-processing and continuous-manufacturing framework that qualifies LNP formation, downstream TFF and aseptic fill-finish.

China

China is the demand-side growth market for mRNA / LNP equipment: a wave of domestic mRNA vaccines (COVID-19, RSV, oncology) and the country’s cell and gene therapy pipeline are converting imported-mixer R&D lines into domestic commercial production, while NMPA’s reliance on ICH Q13 harmonises the continuous-manufacturing framework. Domestic fill-finish and bioprocessing equipment makers are pivoting toward integrated mRNA-LNP preparation lines, but the upstream microfluidic/impingement mixer hardware at production scale remains substantially imported, so the Chinese regional block is held qualitative.

domestic fill-finish pivot, ICH Q13 alignment, imported upstream mixers#

Domestic mRNA vaccine drive: Walvax/Abogen, Stemirna and CSPC mRNA programmes have built commercial-scale LNP capacity around imported NanoAssemblr and Knauer IJM skids, with domestic media, lipid and TFF supply localised around them.
Fill-finish and bioprocessing equipment makers: domestic firms with established aseptic-filling and bioreactor lines are extending into mRNA-LNP preparation skids, but the microfluidic and impingement-jet contactor is still primarily imported at production scale.
NMPA continuous-manufacturing alignment: NMPA adoption of ICH Q13 frames the regulatory route for continuous LNP manufacturing, paralleling FDA and EMA.

6 · Money: tenders & grants

Grant	Textile circularity through advanced processing and manufacturing technologies and system approaches (IA) … European Commission · EU	Feb 2, 2027 109 days
Grant	Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the … National Institutes of Health · United States	Aug 18, 2027 306 days
Grant	Europe-wide environmental benchmarking system of the industrial bioeconomy sectors European Commission · EU	Sep 22, 2027 341 days
Grant	Open topic: Using the Circular Cities and Regions Initiative to strengthen urban manufacturing in support of … European Commission · EU	Apr 8, 2027 174 days

7 · Tech stack & innovations

The stack combines the mixer contactor, the downstream TFF train and continuous-manufacturing control into one closed flow path.

Mixer contactors (Mixer Contactors):
- impingement-jet chambers (Knauer IJM) colliding the two streams at high velocity, scaled by Reynolds-number matching;
- staggered-herringbone microfluidic cartridges (Precision NanoSystems NanoAssemblr) controlling LNP size (30–270 nm) by flow-rate ratio;
- high-pressure fixed-geometry interaction chambers (Microfluidics Microfluidizer) and plate-and-frame AFR contactors (Corning).
Downstream TFF train (Downstream TFF Train):
- single-use tangential-flow cassettes that remove ethanol from the crude LNP dispersion and exchange the buffer to <1% residual organic;
- inline dynamic-light-scattering PAT tracking particle size and polydispersity in real time.
Continuous-manufacturing control (Continuous-Manufacturing Control):
- ICH Q13-aligned process control with flow-rate-ratio and total-flow feedback, enabling true continuous LNP formation rather than batch overflow.

Sources 5 · 0 independent · 5 producer sites

Producers' own sites 5

Precision nanosystems producer checked 2026-04-26 · link not kept
Knauer producer checked 2026-05-29 · link not kept
Microfluidics international producer checked 2025-11-23 · link not kept
Corning producer checked 2026-07-06 · link not kept
Evonik producer checked 2026-01-16 · link not kept